Evidence map›Paper›PMID 22595875›Full record

ArticleEpigenetics2012

Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patient.

Holger Heyn, Enrique Vidal, Sergi Sayols, Jose V Sanchez-Mut, Sebastian Moran, Ignacio Medina, Juan Sandoval, Laia Simó-Riudalbas, Karolina Szczesna, Dori Huertas and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Epigenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 75 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. The aberrant epigenome ofGenome research · 2023
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Holger HeynCancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute, L'Hospitalet de Llobregat; Barcelona, Catalonia, Spain.
Enrique Vidal
Sergi Sayols
Jose V Sanchez-Mut
Sebastian Moran
Ignacio Medina
Juan Sandoval
Laia Simó-Riudalbas
Karolina Szczesna
Dori Huertas
Sole Gatto
Maria R Matarazzo
Joaquin Dopazo
Manel Esteller
Institut d'Investigació Biomédica de Bellvitge · ESManufacturas Serviplast (Spain) · ESCentro de Investigacion Principe Felipe · ESInstitute of Genetics and Biophysics · ITCentre for Biomedical Network Research on Rare Diseases · ES

Funding

European Research Council 268626
6 · The paper itself

Abstract

The immunodeficiency, centromere instability and facial anomalies (ICF) syndrome is associated to mutations of the DNA methyl-transferase DNMT3B, resulting in a reduction of enzyme activity. Aberrant expression of immune system genes and hypomethylation of pericentromeric regions accompanied by chromosomal instability were determined as alterations driving the disease phenotype. However, so far only technologies capable to analyze single loci were applied to determine epigenetic alterations in ICF patients. In the current study, we performed whole-genome bisulphite sequencing to assess alteration in DNA methylation at base pair resolution. Genome-wide we detected a decrease of methylation level of 42%, with the most profound changes occurring in inactive heterochromatic regions, satellite repeats and transposons. Interestingly, transcriptional active loci and ribosomal RNA repeats escaped global hypomethylation. Despite a genome-wide loss of DNA methylation the epigenetic landscape and crucial regulatory structures were conserved. Remarkably, we revealed a mislocated activity of mutant DNMT3B to H3K4me1 loci resulting in hypermethylation of active promoters. Functionally, we could associate alterations in promoter methylation with the ICF syndrome immunodeficient phenotype by detecting changes in genes related to the B-cell receptor mediated maturation pathway.

Indexed as

DNA MethylationB-LymphocytesCell Line, TransformedChild, PreschoolDNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3BEpigenesis, GeneticFaceFemaleGenome, HumanHigh-Throughput Nucleotide SequencingHumansImmunologic Deficiency SyndromesMutationPrimary Immunodeficiency DiseasesSequence Analysis, DNADNA (Cytosine-5-)-MethyltransferasesDNA Methyltransferase 3Bhydrogen sulfiteSulfites

Identifiers

PMID22595875
PMCPMC3398983
OpenAlexW2132478265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.